VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 159 filers reported holding VIKING THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,744,756 | -71.6% | 202,693 | -56.0% | 0.00% | -72.7% |
Q1 2024 | $37,811,806 | +659.2% | 461,082 | +72.3% | 0.01% | +450.0% |
Q4 2023 | $4,980,408 | +70.2% | 267,620 | +1.3% | 0.00% | +100.0% |
Q3 2023 | $2,925,624 | -31.8% | 264,284 | -0.1% | 0.00% | 0.0% |
Q2 2023 | $4,289,085 | +1985587.5% | 264,595 | +1943.5% | 0.00% | – |
Q1 2023 | $216 | -100.0% | 12,948 | -95.1% | 0.00% | – |
Q1 2022 | $855,000 | -76.0% | 263,132 | -66.5% | 0.00% | -100.0% |
Q4 2021 | $3,568,000 | -52.1% | 786,013 | -29.4% | 0.00% | -50.0% |
Q3 2021 | $7,448,000 | +338.6% | 1,113,372 | +292.7% | 0.00% | +100.0% |
Q2 2021 | $1,698,000 | -9.5% | 283,548 | -4.5% | 0.00% | 0.0% |
Q1 2021 | $1,877,000 | +7.5% | 296,758 | -4.3% | 0.00% | 0.0% |
Q4 2020 | $1,746,000 | -40.1% | 310,020 | -38.1% | 0.00% | 0.0% |
Q3 2020 | $2,917,000 | +62.9% | 501,188 | +101.7% | 0.00% | 0.0% |
Q2 2020 | $1,791,000 | +50.4% | 248,470 | -2.3% | 0.00% | 0.0% |
Q1 2020 | $1,191,000 | -41.8% | 254,426 | -0.2% | 0.00% | 0.0% |
Q4 2019 | $2,045,000 | -29.6% | 254,959 | -39.6% | 0.00% | 0.0% |
Q3 2019 | $2,906,000 | +25.7% | 422,401 | +51.7% | 0.00% | 0.0% |
Q2 2019 | $2,312,000 | +264.1% | 278,525 | +235.7% | 0.00% | -75.0% |
Q4 2018 | $635,000 | +29.1% | 82,960 | +193.9% | 0.00% | +33.3% |
Q3 2018 | $492,000 | – | 28,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |